Last reviewed · How we verify
Wistar Rabies Virus Strain PM-1503-3M Vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Wistar Rabies Virus Strain PM-1503-3M Vaccine (Wistar Rabies Virus Strain PM-1503-3M Vaccine) — Fred Hutchinson Cancer Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Wistar Rabies Virus Strain PM-1503-3M Vaccine TARGET | Wistar Rabies Virus Strain PM-1503-3M Vaccine | Fred Hutchinson Cancer Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Wistar Rabies Virus Strain PM-1503-3M Vaccine CI watch — RSS
- Wistar Rabies Virus Strain PM-1503-3M Vaccine CI watch — Atom
- Wistar Rabies Virus Strain PM-1503-3M Vaccine CI watch — JSON
- Wistar Rabies Virus Strain PM-1503-3M Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Wistar Rabies Virus Strain PM-1503-3M Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/wistar-rabies-virus-strain-pm-1503-3m-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab